Biotechnology stocks and exchange traded funds recently retreated as some of the air came out of the coronavirus vaccine trade and amid election year jitters. The ALPS Medical Breakthroughs ETF (SBIO) wasn’t immune to that pullback, but some analysts see opportunity with biotech regardless of...